Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
Read the PCI FY24 Year in Review
1500
Active Commercial Partnership Agreements
150+
Active Penn Spinouts (152)
125
Issued U.S. Patents (+20% from FY23)
#13
Nationally for Utility Patents (NAI Worldwide Universities Granted US Utility Patents)
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
Join PCI in San Francisco this January
In parallel with the 2025 JP Morgan Healthcare Conference, PCI is hosting its annual Innovation @ Penn program in San Francisco on January 13th, 2025. This event is an excellent opportunity to learn about emerging areas of innovation and opportunities for partnership with Penn. The program attracts professionals from across the pharma, MedTech and biotech industries, and investor community, and provides a platform for in-depth discussions about the latest cutting-edge technologies and their practical applications. This year’s program focuses on amazing developments happening at the intersection of Artificial Intelligence (AI) and healthcare innovation
PCI is honored to have a stellar group of leaders and practitioners participating in this year’s panel, including leading luminaries Marylyn Ritchie, PhD, Vice Dean of Artificial Intelligence and Computing, Penn Medicine, David Fajgenbaum, MD, MBA, MSc, Associate Professor of Medicine, Penn Medicine and cofounder of Everycure, and Walter Witschey, PhD, Associate Professor of Radiology, Penn Medicine. Roy Rosin, MBA, Board Partner, First Round Capital will serve as moderator for the panel. You can sign up to attend in person or stream the panel virtually via Zoom.
Available Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologies
Recent News
All NewsMeet the 2024/2025 PCI Fellows Cohort
Penn’s Chief Innovation Officer John Swartley Interviewed by BioBuzz @ Philly Builds Bio+ Symposium and nominated for the Life Science Cares Leader of the Year Award
Michael Kahana Featured in NY Post for Memory Research
Penn Engineering’s Shu Yang to Co-Design Artificial Reef Structures that Help Harness Wave Energy
Learn about the Rich History of PCI
The Penn Gazette wrote an incredible piece about PCI and its role in Penn’s successes in research and innovation over the past decade. Founded in 2014, PCI has since consolidated efforts across the university to create strategic partnerships and move groundbreaking ideas from academia to industry, significantly boosting Penn’s entrepreneurial and innovation capabilities.
The article explains how PCI has enabled Penn faculty to translate their research into marketable products, resulting in record-breaking revenues and establishing the university as a clear leader in innovation.
The article also highlights how PCI provided crucial support in navigating the commercialization process for world-renowned Penn-invented technologies, including CAR T cell therapy and the mRNA technology that made the life-saving COVID-19 vaccines possible.
Download Penn Startups Raising Money List
Learn about which Penn startup companies are raising money in 2024 with this comprehensive list. With companies in connected health, digital health, diagnostics, therapeutics, and medical devices, Penn offers a wide range of rapidly emerging companies at all investment levels.
If you are interested in connecting about these startups, please email Laurie Actman (lactman@upenn.edu).
Download and view the complete list
Discover CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.